Literature DB >> 27150750

Acute effects of sono-activated photocatalytic titanium dioxide nanoparticles on oral squamous cell carcinoma.

S Moosavi Nejad1, Hiromasa Takahashi2, Hamid Hosseini3, Akiko Watanabe4, Hitomi Endo4, Kyoichi Narihira2, Toshihiro Kikuta2, Katsuro Tachibana4.   

Abstract

Sonodynamic therapy (SDT) is a new treatment modality using ultrasound to activate certain chemical sensitizers for cancer therapy. In this study, effects of high intensity focused ultrasound (HIFU) combined with photocatalytic titanium dioxide (TiO2) nanoparticles on human oral squamous cell line HSC-2 were investigated. Viability of HSC-2 cells after 0, 0.1, 1, or 3s of HIFU irradiation with 20, 32, 55 and 73Wcm(-2) intensities in the presence or absence of TiO2 was measured immediately after the exposures in vitro. Immediate effects of HIFU (3s, 73Wcm(-2)) combined with TiO2 on solid tumors were also examined by histological study. Cytotoxic effect of HIFU+TiO2in vitro was significantly higher than that of TiO2 or HIFU alone with the tendency to increase for higher HIFU intensity, duration, and TiO2 concentration in the suspension. In vivo results showed significant necrosis and tissue damage in HIFU and HIFU+TiO2 treated samples. However, penetration of TiO2 nanoparticles into the cell cytoplasm was only observed in HIFU+TiO2 treated tissues. In this study, our findings provide a rational basis for the development of an effective HIFU based sonodynamic activation method. This approach offers an attractive non-invasive therapy technique for oral cancer in future.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  High intensity focused ultrasound (HIFU); Oral squamous cell carcinoma; Photocatalytic titanium dioxide (TiO(2)) nanoparticles; Sonodynamic therapy

Mesh:

Substances:

Year:  2016        PMID: 27150750     DOI: 10.1016/j.ultsonch.2016.02.026

Source DB:  PubMed          Journal:  Ultrason Sonochem        ISSN: 1350-4177            Impact factor:   7.491


  7 in total

1.  Nanoparticles of Titanium and Zinc Oxides as Novel Agents in Tumor Treatment: a Review.

Authors:  Janusz Bogdan; Joanna Pławińska-Czarnak; Joanna Zarzyńska
Journal:  Nanoscale Res Lett       Date:  2017-03-27       Impact factor: 4.703

2.  Nanoparticle-assisted ultrasound: A special focus on sonodynamic therapy against cancer.

Authors:  Giancarlo Canavese; Andrea Ancona; Luisa Racca; Marta Canta; Bianca Dumontel; Federica Barbaresco; Tania Limongi; Valentina Cauda
Journal:  Chem Eng J       Date:  2018-05-15       Impact factor: 13.273

Review 3.  Biomaterial-based strategies for maxillofacial tumour therapy and bone defect regeneration.

Authors:  Bowen Tan; Quan Tang; Yongjin Zhong; Yali Wei; Linfeng He; Yanting Wu; Jiabao Wu; Jinfeng Liao
Journal:  Int J Oral Sci       Date:  2021-03-16       Impact factor: 6.344

Review 4.  Adverse Outcome Pathways Associated with the Ingestion of Titanium Dioxide Nanoparticles-A Systematic Review.

Authors:  Dora Rolo; Ricardo Assunção; Célia Ventura; Paula Alvito; Lídia Gonçalves; Carla Martins; Ana Bettencourt; Peter Jordan; Nádia Vital; Joana Pereira; Fátima Pinto; Paulo Matos; Maria João Silva; Henriqueta Louro
Journal:  Nanomaterials (Basel)       Date:  2022-09-21       Impact factor: 5.719

Review 5.  High-Intensity Focused Ultrasound: A Review of Mechanisms and Clinical Applications.

Authors:  Vismaya S Bachu; Jayanidhi Kedda; Ian Suk; Jordan J Green; Betty Tyler
Journal:  Ann Biomed Eng       Date:  2021-08-10       Impact factor: 4.219

Review 6.  Future trends and emerging issues for nanodelivery systems in oral and oropharyngeal cancer.

Authors:  Alexandra Iulia Irimie; Laura Sonea; Ancuta Jurj; Nikolay Mehterov; Alina Andreea Zimta; Liviuta Budisan; Cornelia Braicu; Ioana Berindan-Neagoe
Journal:  Int J Nanomedicine       Date:  2017-06-26

7.  The application of titanium dioxide (TiO2) nanoparticles in the photo-thermal therapy of melanoma cancer model.

Authors:  Mohammad Ali Behnam; Farzin Emami; Zahra Sobhani; Amir Reza Dehghanian
Journal:  Iran J Basic Med Sci       Date:  2018-11       Impact factor: 2.699

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.